Enhanced effects of 1,25(OH)"2D"3 plus genistein on adipogenesis and apoptosis in 3T3-L1 adipocytes

Obesity

Volumn 16, Issue 3, 2008, Pages 539-546

  Rayalam, Srujana ^a   Anne Della Fera, Mary ^a   Ambati, Suresh ^a   Yang, Jeong Yeh ^a   Jin Park, Hea ^a   Baile, Clifton A ^a,b  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 40149090479     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2007.90     Document Type: Article

References (43)

1. 1 Drent ML, van der Veen EA. Endocrine aspects of obesity. Neth J Med 1995 ; 47: 127–136.
2. 2 Somjen D., Kaye AM, Harell A., Weisman Y.. Modulation by vitamin D status of the responsiveness of rat bone to gonadal steroids. Endocrinology 1989 ; 125: 1870–1876.
3. 3 Safe SH. Environmental and dietary estrogens and human health: is there a problem? Environ Health Perspect 1995 ; 103: 346–351.
4. 4 Feldman D.. Estrogens from plastic—are we being exposed? Endocrinology 1997 ; 138: 1777–1779.
5. 5 McCarty MF. Isoflavones made simple—genistein's agonist activity for the beta‐type estrogen receptor mediates their health benefits. Med Hypotheses 2006 ; 66: 1093–1114.
6. 6 Ishimi Y., Miyaura C., Ohmura M. et al. Selective effects of genistein, a soybean isoflavone, on B‐lymphopoiesis and bone loss caused by estrogen deficiency. Endocrinology 1999 ; 140: 1893–1900.
7. 7 Kim HK, Nelson‐Dooley C., Della‐Fera MA et al. Genistein decreases food intake, body weight, and fat pad weight and causes adipose tissue apoptosis in ovariectomized female mice. J Nutr 2006 ; 136: 409–414.
8. 8 Naaz A., Yellayi S., Zakroczymski MA et al. The soy isoflavone genistein decreases adipose deposition in mice. Endocrinology 2003 ; 144: 3315–3320.
9. 9 Kandulska K., Nogowski L., Szkudelski T.. Effect of some phytoestrogens on metabolism of rat adipocytes. Reprod Nutr Dev 1999 ; 39: 497–501.
10. 10 Messina MJ, Loprinzi CL. Soy for breast cancer survivors: a critical review of the literature. J Nutr 2001 ; 131 (Suppl 11): S3095–S3108.
11. 11 Zhou YS, Liu YS, Tan JG. Is 1, 25‐dihydroxyvitamin D3 an ideal substitute for dexamethasone for inducing osteogenic differentiation of human adipose tissue‐derived stromal cells in vitro ? Chin Med J (Engl) 2006 ; 119: 1278–1286.
12. 12 Kong J., Li YC. Molecular mechanism of 1, 25‐dihydroxyvitamin D3 inhibition of adipogenesis in 3T3‐L1 cells. Am J Physiol Endocrinol Metab 2006 ; 290: E916–E924.
13. 13 Sun X., Zemel MB. Role of uncoupling protein 2 (UCP2) expression and 1alpha, 25‐dihydroxyvitamin D3 in modulating adipocyte apoptosis. Faseb J 2004 ; 18: 1430–1432.
14. 14 Pietschmann P., Schernthaner G., Woloszczuk W.. Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications. Diabetologia 1988 ; 31: 892–895.
15. 15 Scragg R., Holdaway I., Singh V. et al. Serum 25‐hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract 1995 ; 27: 181–188.
16. 16 Isaia G., Giorgino R., Adami S.. High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care 2001 ; 24: 1496.
17. 17 Scragg R., Sowers M., Bell C.. Serum 25‐hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004 ; 27: 2813–2818.
18. 18 Boucher BJ, Mannan N., Noonan K., Hales CN, Evans SJ. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia 1995 ; 38: 1239–1245.
19. 19 Fournier B., Haring S., Kaye AM, Somjen D.. Stimulation of creatine kinase specific activity in human osteoblast and endometrial cells by estrogens and anti‐estrogens and its modulation by calciotropic hormones. J Endocrinol 1996 ; 150: 275–285.
20. 20 Bellido T., Girasole G., Passeri G. et al. Demonstration of estrogen and vitamin D receptors in bone marrow‐derived stromal cells: up‐regulation of the estrogen receptor by 1,25‐dihydroxyvitamin‐D3. Endocrinology 1993 ; 133: 553–562.
21. 21 Hedlund TE, Moffatt KA, Miller GJ. Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA‐1: evidence that the antiproliferative effects of 1 alpha, 25‐dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway. Endocrinology 1996 ; 137: 1554–1561.
22. 22 Swami S., Krishnan AV, Peehl DM, Feldman D.. Genistein potentiates the growth inhibitory effects of 1, 25‐dihydroxyvitamin D3 in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activity. Mol Cell Endocrinol 2005 ; 241: 49–61.
23. 23 Tang QQ, Lane MD. Activation and centromeric localization of CCAAT/enhancer‐binding proteins during the mitotic clonal expansion of adipocyte differentiation. Genes Dev 1999 ; 13: 2231–2241.
24. 24 Cornelius P., MacDougald OA, Lane MD. Regulation of adipocyte development. Annu Rev Nutr 1994 ; 14: 99–129.
25. 25 Rosen ED, Hsu CH, Wang X. et al. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev 2002 ; 16: 22–26.
26. 26 Harmon AW, Harp JB. Differential effects of flavonoids on 3T3‐L1 adipogenesis and lipolysis. Am J Physiol Cell Physiol 2001 ; 280: C807–C813.
27. 27 Harmon AW, Patel YM, Harp JB. Genistein inhibits CCAAT/enhancer‐binding protein beta (C/EBPbeta) activity and 3T3‐L1 adipogenesis by increasing C/EBP homologous protein expression. Biochem J 2002 ; 367 (Pt 1): 203–208.
28. 28 Blumberg JM, Tzameli I., Astapova I. et al. Complex role of the vitamin D receptor and its ligand in adipogenesis in 3T3‐L1 cells. J Biol Chem 2006 ; 281: 11205–11213.
29. 29 Hemati N., Ross SE, Erickson RL et al. Signaling pathways through which insulin regulates CCAAT/enhancer binding protein alpha (C/EBPalpha) phosphorylation and gene expression in 3T3‐L1 adipocytes. Correlation with GLUT4 gene expression. J Biol Chem 1997 ; 272: 25913–25919.
30. 30 Suryawan A., Hu CY. Effect of serum on differentiation of porcine adipose stromal‐vascular cells in primary culture. Comp Biochem Physiol Comp Physiol 1993 ; 105: 485–492.
31. 31 Frankfurt OS. Immunoassay for single‐stranded DNA in apoptotic cells. Methods Mol Biol 2004 ; 282: 85–101.
32. 32 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970 ; 227: 680–685.
33. 33 Prins JB, O'Rahilly S.. Regulation of adipose cell number in man. Clin Sci (Lond) 1997 ; 92: 3–11.
34. 34 Sato M., Hiragun A.. Demonstration of 1 alpha, 25‐dihydroxyvitamin D3 receptor‐like molecule in ST 13 and 3T3 L1 preadipocytes and its inhibitory effects on preadipocyte differentiation. J Cell Physiol 1988 ; 135: 545–550.
35. 35 Kawada T., Kamei Y., Sugimoto E.. The possibility of active form of vitamins A and D as suppressors on adipocyte development via ligand‐dependent transcriptional regulators. Int J Obes Relat Metab Disord 1996 ; 20 (Suppl 3): S52–S57.
36. 36 Hida Y., Kawada T., Kayahashi S., Ishihara T., Fushiki T.. Counteraction of retinoic acid and 1, 25‐dihydroxyvitamin D3 on up‐regulation of adipocyte differentiation with PPAR gamma ligand, an antidiabetic thiazolidinedione, in 3T3‐L1 cells. Life Sciences 1998 ; 62: Pl205–Pl211.
37. 37 Kelly KA, Gimble JM. 1,25‐Dihydroxy vitamin D‐3 inhibits adipocyte differentiation and gene expression in murine bone marrow stromal cell clones and primary cultures. Endocrinology 1998 ; 139: 2622–2628.
38. 38 Atmani H., Chappard D., Basle MF. Proliferation and differentiation of osteoblasts and adipocytes in rat bone marrow stromal cell cultures: effects of dexamethasone and calcitriol. J Cell Biochem 2003 ; 89: 364–372.
39. 39 Mezei O., Banz WJ, Steger RW et al. Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J Nutr 2003 ; 133: 1238–1243.
40. 40 Nogowski L., Mackowiak P., Kandulska K., Szkudelski T., Nowak KW. Genistein‐induced changes in lipid metabolism of ovariectomized rats. Ann Nutr Metab 1998 ; 42: 360–366.
41. 41 Wu Z., Bucher NL, Farmer SR. Induction of peroxisome proliferator‐activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids. Mol Cell Biol 1996 ; 16: 4128–4136.
42. 42 Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev 1998 ; 78: 783–809.
43. 43 Farhan H., Wahala K., Adlercreutz H., Cross HS. Isoflavonoids inhibit catabolism of vitamin D in prostate cancer cells. J Chromatogr B Analyt Technol Biomed Life Sci 2002 ; 777: 261–268.